Gene · 28402
Papers3,091
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 3,091
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ibrutinib-Associated Cardiotoxicity: From the Pharmaceutical to the Clinical. | Drug Des Devel Ther | 2022 | 36164415 | PubTator, text mining | PubMed |
| Hematologic Malignancies: 2022 ASCO Annual Meeting Highlights for the Advanced Practitioner. | J Adv Pract Oncol | 2022 | 36160061 | PubTator, text mining | PubMed |
| The Long and the Short of It: NEAT1 and Cancer Cell Metabolism. | Cancers (Basel) | 2022 | 36139550 | PubTator, text mining | PubMed |
| Management of relapsed/refractory Chronic Lymphocytic Leukemia. | Am J Hematol | 2022 | 36125037 | PubTator, text mining | PubMed |
| Management of front line chronic lymphocytic leukemia. | Am J Hematol | 2022 | 36125035 | PubTator, text mining | PubMed |
| Increased serum level of alpha-2 macroglobulin and its production by B-lymphocytes in chronic lymphocytic leukemia. | Front Immunol | 2022 | 36119042 | PubTator, text mining | PubMed |
| Dual targeting fixed duration frontline monoclonal antibody therapy for chronic lymphocytic leukemia: A phase 2 study. | Leuk Res | 2022 | 36115087 | PubTator, text mining | PubMed |
| The rs1001179 SNP and CpG methylation regulate catalase expression in chronic lymphocytic leukemia. | Cell Mol Life Sci | 2022 | 36112236 | PubTator, text mining | PubMed |
| Gastric DLBCL clonal evolution as function of patient age. | Front Immunol | 2022 | 36105806 | PubTator, text mining | PubMed |
| Enhanced IFN Sensing by Aggressive Chronic Lymphocytic Leukemia Cells. | J Immunol | 2022 | 36104109 | PubTator, text mining | PubMed |
| FIRE Study: Real-World Effectiveness and Safety of Ibrutinib in Clinical Practice in Patients with CLL and MCL. | Clin Hematol Int | 2022 | 36103041 | PubTator, text mining | PubMed |
Lower access to risk stratification tests and drugs, and worse survival of chronic lymphocytic leukaemia patients treated in public as compared to private hospitals in Brazil: A retrospective analysis of the Brazilian registry of chronic lymphocytic leukaemia. | EJHaem | 2022 | 36051063 | PubTator, text mining | PubMed |
| Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib. | Blood Cancer J | 2022 | 36050317 | PubTator, text mining | PubMed |
| GSK3β is a critical, druggable component of the network regulating the active NOTCH1 protein and cell viability in CLL. | Cell Death Dis | 2022 | 36050315 | PubTator, text mining | PubMed |
| Ibrutinib as a treatment of hematologic autoimmune disorders in patients with indolent B-cell lymphoma. | Eur J Haematol | 2022 | 36048142 | PubTator, text mining | PubMed |
| Loss of AID exacerbates the malignant progression of CLL. | Leukemia | 2022 | 36042317 | PubTator, text mining | PubMed |
| Spatial organization and early signaling of the B-cell receptor in CLL. | Front Immunol | 2022 | 36016925 | PubTator, text mining | PubMed |
| Efficacy and safety profile of COVID-19 mRNA vaccine in patients with hematological malignancies: Systematic review and meta-analysis. | Front Oncol | 2022 | 36003763 | PubTator, text mining | PubMed |
| Plasma cells arise from differentiation of clonal lymphocytes and secrete IgM in Waldenström macroglobulinemia. | iScience | 2022 | 35992066 | PubTator, text mining | PubMed |
| COVID-19-specific transcriptomic signature detectable in blood across multiple cohorts. | Front Genet | 2022 | 35991542 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28402/papers?page=27